1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Wound Closure Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chronic and acute wounds among people
5.1.1.2. Government initiatives regarding wound care treatment
5.1.1.3. Expansion of burn-care centers in economies with improving healthcare infrastructure
5.1.2. Restraints
5.1.2.1. High cost of wound closure device
5.1.3. Opportunities
5.1.3.1. Ongoing development of advanced wound care technologies
5.1.3.2. Rising approvals for the commercialization of wound closure devices
5.1.4. Challenges
5.1.4.1. Complications and probable side effect with the use of wound closure device
5.2. Market Segmentation Analysis
5.2.1. Product: Rising preference for sutures in wound closure devices
5.2.2. Application: Increasing usage of wound closure devices in general surgery for faster healing times
5.2.3. Wound Type: Growing application of wound closure devices for acute wounds to promote healing
5.2.4. End-User: Expanding adoption of wound closure devices in hospitals for surgical procedures
5.3. Market Trend Analysis
5.3.1. Established infrastructure development and robust strategic initiatives by players to deploy next generation device across Americas
5.3.2. Rising expansion activities by the global players and along with evolving healthcare sector in the Asia-Pacific region
5.3.3. Increasing development of novel wound closure devices with robust foothold of global players in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Wound Closure Devices Market, by Product
6.1. Introduction
6.2. Adhesives
6.3. Mechanical Wound Closure Devices
6.4. Sealants
6.5.1. Collagen Based
6.5.2. Non-Synthetic
6.5.3. Synthetic
6.5. Staples
6.6. Strips
6.7.1. Non-Sterile
6.7.2. Sterile
6.7. Sutures
6.8.1. Absorbable
6.8.2. Non-Absorbable
7. Wound Closure Devices Market, by Wound Type
7.1. Introduction
7.2. Acute Wounds
7.3. Chronic Wounds
8. Wound Closure Devices Market, by Application
8.1. Introduction
8.2. Burns
8.3. Cardiology
8.4. Diabetic Foot Ulcers
8.5. General Surgery
8.6. Gynaecology
8.7. Ophthalmic
8.8. Orthopedics
9. Wound Closure Devices Market, by End-User
9.1. Introduction
9.2. Burn Care Centers
9.3. Clinics
9.4. Home Care Setting
9.5. Hospital
10. Americas Wound Closure Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Wound Closure Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Wound Closure Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Coloplast A/S to Acquire Wound Care Company Kerecis for USD 1.3 Billion
13.3.1.2. Tube Investments, Premji Invest Partner Up To Acquire Lotus Surgicals For INR 348 Crore
13.3.1.3. Gentell, Inc. Completed the Acquisition of Non-Core Traditional Wound Care Business of Integra LifeSciences Holdings Corporation
13.3.1.4. Entry Into the Attractive Wound Biologics Segment Through the Acquisition of Triad Life Sciences Inc.
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. MediWound Announces Collaboration with 3M on EscharEx Phase III Study
13.3.2.2. SYNDEO Medical Announces Multi-Year Strategic Distribution Agreement with Clozex Medical, Inc.
13.3.2.3. KitoTech Medical Inc. Signs Agreement with Synergy Corporation for International Distribution of Their Medical and Consumer Products
13.3.2.4. KitoTech Medical Signs Agreement with Corza Medical to Market microMend PRO Wound Closure Devices in the U.S.
13.3.3. New Product Launch & Enhancement
13.3.3.1. Evonik Company JeNaCell Launches Wound Dressing Epicite Balance for Chronic Wounds
13.3.3.2. Introducing Antibacterial Suture Range
13.3.4. Award, Recognition, & Expansion
13.3.4.1. Bactiguard Launches Wound Care Line in the UK and Ireland
13.3.4.2. AMS Receives FDA Clearance for New Wound Closure Device
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 3M Company
14.1.2. Abbott Laboratories
14.1.3. Advanced Medical Solutions Group PLC
14.1.4. Arthrex, Inc.
14.1.5. Artivion, Inc.
14.1.6. B. Braun SE
14.1.7. Bactiguard AB
14.1.8. Baxter International Inc.
14.1.9. Becton, Dickinson and Company
14.1.10. Boston Scientific Corporation
14.1.11. Cardinal Health, Inc.
14.1.12. Clozex Medical, Inc.
14.1.13. Coloplast A/S
14.1.14. Convatec Group PLC
14.1.15. DermaClip US, LLC
14.1.16. DermaRite Industries, LLC
14.1.17. DeRoyal Industries, Inc.
14.1.18. Dolphin Sutures by Futura Surgicare Pvt Ltd
14.1.19. DUKAL Corporation
14.1.20. DuPont de Nemours, Inc.
14.1.21. Evonik Industries AG
14.1.22. Gentell
14.1.23. Harro Höfliger Verpackungsmaschinen GmbH
14.1.24. Healiva SA
14.1.25. Inotec AMD Limited
14.1.26. Integra LifeSciences Holdings Corporation
14.1.27. Johnson & Johnson Services, Inc.
14.1.28. McKesson Corporation
14.1.29. Medela AG
14.1.30. MediWound
14.1.31. Medline Industries, LP
14.1.32. Medtronic PLC
14.1.33. Mölnlycke Health Care AB
14.1.34. RedDress Medical Ltd.
14.1.35. Riverpoint Medical
14.1.36. Sky Medical Technology Ltd.
14.1.37. Smith & Nephew PLC
14.1.38. Spectral AI, Inc.
14.1.39. Stryker Corporation
14.1.40. SYLKE
14.1.41. Teleflex Incorporated
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer